Simtra BioPharma Solutions Expands Bloomington, Indiana, Operations
05/07/2024
The investment will include the construction of a new 150,000-square-foot facility featuring two high-speed automated isolator syringe fill lines and a new high speed isolator vial line equipped with three 30 square meter lyophilizers. The expansion is scheduled for completion in late 2026.
"We are experiencing a broad increase in demand and need for injectable manufacturing in therapeutic classes such as GLP-1 drugs and product categories such Antibody-Drug-Conjugates as well as overall continued growth of the oncology pipeline," said Franco Negron, CEO of Simtra BioPharma Solutions. "Our customers consider our sites in Halle and Bloomington as an extension of their manufacturing network, so we are thrilled to further enhance our capabilities and resources to help them meet their respective goals. This expansion is the latest in a series of strategic, long-term investments to ensure that Simtra continues to grow with and for our customers."
Based on the company’s job creation plans, the Indiana Economic Development Corporation (IEDC) committed an investment in Simtra of up to $1.6 million in the form of incentive-based tax credits. These tax credits are performance-based, meaning the company is eligible to claim incentives once Hoosiers are hired.
“Indiana is a growing life sciences leader, advancing critical R&D and delivering life-changing pharmaceuticals and solutions for people around the world,” noted Ann Lathrop, chief strategy officer at the Indiana Economic Development Corporation (IEDC). “Simtra is an important part of this ecosystem, and the company’s expansion will catalyze quality job opportunities, economic growth, and industry momentum for years to come.”
Additionally, the Bloomington Economic Development Corporation (BEDC) supported Simtra BioPharma Solutions in its application for tax abatements.
"Simtra's expansion with this project represents a significant win for Monroe County’s economic landscape,” noted Jennifer Pearl, president of the Bloomington Economic Development Corporation. “This investment not only creates high-quality jobs but also reinforces our community's reputation as a hub for innovation and growth in the biopharmaceutical industry. We are proud to support Simtra in their endeavors, grateful to Monroe County and the state for their support of the expansion, and look forward to the continued success of this partnership."
Simtra BioPharma Solutions, a trade name of Baxter Oncology GmbH and Baxter Pharmaceutical LLC, offers world-class cGMP sterile fill/finish, technical expertise, quality service, and a uniquely collaborative approach. The expansion announcement follows the company’s recent acquisition by Advent International, a global private equity investor, and Warburg Pincus, a global growth investor.
Project Announcements
Herr Foods Establishes Jackson, Ohio, Operations
05/17/2024
SRC of Lexington Expands Fayette County, Kentucky, Operations
05/17/2024
John Deere Expands Kernersville, North Carolina, Production Operations
05/17/2024
Japan-Based Asahi Kasei Plans Port Colborne, Ontario, EV Battery Operations
05/17/2024
Microsoft Establishes Mount Pleasant, Wisconsin, Data Center Operations
05/16/2024
BlueHalo Establishes Germantown, Maryland, Production Operations
05/16/2024
Most Read
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
38th Annual Corporate Survey: Are Unrealized Predictions of an Economic Slump Leading Small to Mid-Size Companies to Put Off Expansion Plans?
Q1 2024
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
Making Hybrid More Human in 2024
Q1 2024
-
20th Annual Consultants Survey: Clients Prioritize Access to Skilled Labor, Responsive State & Local Government
Q1 2024
-
Manufacturing Momentum Is Building
Q1 2024
-
The Bring Your Own Energy (BYOE) Party Is Starting
Q2 2024